Lian‐Wen Qi

12.6k total citations
231 papers, 10.5k citations indexed

About

Lian‐Wen Qi is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, Lian‐Wen Qi has authored 231 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 164 papers in Molecular Biology, 70 papers in Complementary and alternative medicine and 54 papers in Pharmacology. Recurrent topics in Lian‐Wen Qi's work include Ginseng Biological Effects and Applications (67 papers), Traditional Chinese Medicine Analysis (62 papers) and Natural product bioactivities and synthesis (49 papers). Lian‐Wen Qi is often cited by papers focused on Ginseng Biological Effects and Applications (67 papers), Traditional Chinese Medicine Analysis (62 papers) and Natural product bioactivities and synthesis (49 papers). Lian‐Wen Qi collaborates with scholars based in China, United States and Japan. Lian‐Wen Qi's co-authors include Ping Li, Chong‐Zhi Wang, Chun‐Su Yuan, E‐Hu Liu, Ling Yi, Xiaodong Wen, Raphael N. Alolga, Jian‐Liang Zhou, Baolin Liu and Qun Liu and has published in prestigious journals such as Journal of the American Chemical Society, Circulation and Nature Communications.

In The Last Decade

Lian‐Wen Qi

227 papers receiving 10.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lian‐Wen Qi China 60 6.7k 2.5k 2.4k 1.4k 1.2k 231 10.5k
Aihua Zhang China 64 8.5k 1.3× 3.3k 1.3× 2.0k 0.8× 948 0.7× 1.2k 1.0× 254 12.4k
Chong‐Zhi Wang United States 52 5.9k 0.9× 1.3k 0.5× 2.5k 1.0× 1.2k 0.9× 535 0.5× 222 9.5k
Richard B. van Breemen United States 70 7.4k 1.1× 1.2k 0.5× 2.9k 1.2× 2.1k 1.5× 676 0.6× 404 16.6k
Yuping Tang China 52 5.0k 0.7× 2.2k 0.9× 1.9k 0.8× 2.1k 1.5× 463 0.4× 437 9.9k
Ling‐Yi Kong China 50 5.2k 0.8× 1.1k 0.4× 1.4k 0.6× 1.9k 1.4× 630 0.5× 375 9.8k
Feng Qiu China 50 4.5k 0.7× 1.9k 0.8× 1.5k 0.6× 1.6k 1.1× 468 0.4× 381 9.5k
Changxiao Liu China 44 4.0k 0.6× 1.6k 0.6× 2.2k 0.9× 1.1k 0.8× 283 0.2× 308 7.6k
De‐an Guo China 57 7.6k 1.1× 4.0k 1.6× 2.6k 1.1× 2.8k 2.0× 376 0.3× 466 12.3k
Hubiao Chen Hong Kong 47 4.0k 0.6× 1.4k 0.6× 1.1k 0.5× 1.9k 1.3× 402 0.3× 227 7.1k
Hermann Stuppner Austria 51 5.3k 0.8× 1.4k 0.5× 1.4k 0.6× 3.7k 2.7× 857 0.7× 358 11.5k

Countries citing papers authored by Lian‐Wen Qi

Since Specialization
Citations

This map shows the geographic impact of Lian‐Wen Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lian‐Wen Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lian‐Wen Qi more than expected).

Fields of papers citing papers by Lian‐Wen Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lian‐Wen Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lian‐Wen Qi. The network helps show where Lian‐Wen Qi may publish in the future.

Co-authorship network of co-authors of Lian‐Wen Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Lian‐Wen Qi. A scholar is included among the top collaborators of Lian‐Wen Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lian‐Wen Qi. Lian‐Wen Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Feng-Qing, Hongfei Wang, Yang Dai, et al.. (2025). Ceramides increase mitochondrial permeabilization to trigger mtDNA-dependent inflammation in astrocytes during brain ischemia. Metabolism. 166. 156161–156161. 8 indexed citations
2.
Wang, Jiwen, Gaoxiang Ma, Feng‐Qing Huang, et al.. (2025). N-Acetyl-Tryptophan in Acute Kidney Injury after Cardiac Surgery. Journal of the American Society of Nephrology. 36(6). 1040–1055. 1 indexed citations
4.
5.
Wu, Wenhui, et al.. (2024). Ginsenoside compound K restrains hepatic fibrotic response by dual-inhibition of GLS1 and LDHA. Phytomedicine. 135. 156223–156223. 2 indexed citations
7.
Wu, Wenhui, Kechang Niu, W Zhang, et al.. (2024). Xinkeshu formula restrains pathological cardiac hypertrophy through metabolic remodeling via AMPK/mTOR pathway. Phytomedicine. 136. 156309–156309. 1 indexed citations
8.
Yin, Xiaojian, Xinyao Zhang, Chao Ma, et al.. (2023). Upregulation of glycolytic enzyme PFKFB3 by deubiquitinase OTUD4 promotes cardiac fibrosis post myocardial infarction. Journal of Molecular Medicine. 101(6). 743–756. 11 indexed citations
9.
Wang, Zi-Chao, et al.. (2022). A dual Keap1 and p47phox inhibitor Ginsenoside Rb1 ameliorates high glucose/ox-LDL-induced endothelial cell injury and atherosclerosis. Cell Death and Disease. 13(9). 824–824. 42 indexed citations
10.
11.
Wang, Chong‐Zhi, Jin‐Yi Wan, Jin‐Yi Wan, et al.. (2020). Human intestinal microbiota derived metabolism signature from a North American native botanical Oplopanax horridus with UPLC/Q‐TOF–MS analysis. Biomedical Chromatography. 34(10). e4911–e4911. 4 indexed citations
12.
Gao, Yingsheng, Minyi Qian, Shi-Lei Wang, et al.. (2019). WZ66, a novel acetyl-CoA carboxylase inhibitor, alleviates nonalcoholic steatohepatitis (NASH) in mice. Acta Pharmacologica Sinica. 41(3). 336–347. 25 indexed citations
13.
Yang, Yilin, Lan‐Zhu Li, Lei Zhang, et al.. (2017). Succinate accumulation impairs cardiac pyruvate dehydrogenase activity through GRP91-dependent and independent signaling pathways: Therapeutic effects of ginsenoside Rb1. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863(11). 2835–2847. 46 indexed citations
14.
Huang, Zebo, Danxia Zhu, Lirong Wu, et al.. (2016). Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer. Cancer Epidemiology Biomarkers & Prevention. 26(2). 188–196. 114 indexed citations
15.
Fan, Yong, Xin Zhou, Tiansong Xia, et al.. (2016). Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer. Oncotarget. 7(9). 9925–9938. 84 indexed citations
16.
Yang, Lele, Na Xiao, Xiaowei Li, et al.. (2016). Pharmacokinetic comparison between quercetin and quercetin 3-O-β-glucuronide in rats by UHPLC-MS/MS. Scientific Reports. 6(1). 35460–35460. 74 indexed citations
18.
Li, Xiaorong, Ting Jiang, Bing Gu, et al.. (2014). Effects of different LAD-blocked sites on the development of acute myocardial infarction and malignant arrhythmia in a swine model.. PubMed. 6(9). 1271–7. 12 indexed citations
19.
Wang, Chong-Zhi, Karen Kim, Lian‐Wen Qi, et al.. (2011). Ultra-Performance Liquid Chromatography and Time-of-Flight Mass Spectrometry Analysis of Ginsenoside Metabolites in Human Plasma. The American Journal of Chinese Medicine. 39(6). 1161–1171. 66 indexed citations
20.
Cao, Jun, Lian‐Wen Qi, Jun Chen, & Ping Li. (2008). Pressure and electrokinetic injections for on‐line sample stacking neutral analytes in microemulsion electrokinetic chromatography with salt‐containing matrixes. Electrophoresis. 29(21). 4422–4430. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026